Targeting aging-related mechanisms could be a potentially useful therapeutic approach in multiple sclerosis (MS), researchers have concluded, after finding that biologic aging may be a significant independent contributor to neurologic injury.
Targeting aging-related mechanisms could be a potentially useful therapeutic approach in multiple sclerosis (MS), researchers have concluded, after finding that biologic aging may be a significant independent contributor to neurologic injury.